Even Wordle is getting on board! #treatabletraits #wednesdayswordle

So great to have this paper published. A new understanding of how #COPD developed. Nice team work and collaboration.Keshav Raj Paudel Monica (Wenying) Lu Ridhima Wadhwa Vamshi, PhD Michael Fricker Kamal Dua Mathew Suji Eapen Ken Bracke Sukhwinder Singh Sohal 🫁 Peter Wark Hansbro Research

A bit of history at Traits head quarters today! Do you have vintage inhaler hanging around?

Noneosinophilic asthma (T2-low) is difficult to treat. In this #mustread Review in Annals of Allergy, Asthma & Immunology Drs. Niessen Michael Fricker Vanessa McDonald and Gibson discuss clinical trials, biomarkers, and treatments for this difficult disease. ACAAI #MedTwitter #asthma doi.org/10.1016/j.anai…

📣Spread the word: I have a part-time Clinical Research Officer position available (based at Mehdi). Join a collaborative team of clinical researchers working with volunteers to improve outcomes in asthma. Contact me directly for details.

Knowing what to call your "Lung macrophage" can be so hard- alveolar v airway v lung but this great review on the biology of lung macrophages in health and disease Immunity is helping us to start defining better well done Claudia Jakubzick lab 🫁👏 cell.com/immunity/fullt…

I want to test the power of Twitter.. If I can ask one thing of you today, if you see this thread on your timeline, PLEASE can you RETWEET it. If you are disinterested, or already know the story, that's okay. But someone who follows you, may want to read on.. RUNDIPG

Depressing but amazing work describing the dramatic impact of historical redlining (instutitionalised racism) on asthma. Thank you Dr Shuyler, Sally Wenzel published in ATS Blue Journal atsjournals.org/doi/10.1164/rc…

A Case Series of Dual Biologics Therapy for #SevereAsthma - sciencedirect.com/science/articl…. Combined inhibition of IL5 and IL4/13 improved outcomes for those with inadequate response to single therapy 👍#endotype #biomarker

Exciting times

We find T2 inflammation to be more prevalent in SA and that biomarker expression relating to more than one pathway to be a particular trait of SA. Our findings also highlight the need for clinically feasible airway inflammometry as 22% of patients had airway eos without blood eos

We got some key things wrong about long COVID. Here are 5 things we've learnt theconversation.com/we-got-some-ke… via The Conversation - Australia + New Zealand

🚨Dupilumab works in #COPD 🚨Eosinophilic COPD can be targeted 🚨Improvements in lung function, exacerbations and quality of life! #ATS2023 nejm.org/doi/full/10.10…

Please RT: We are seeking EOIs for a part-time (0.6-0.8 FTE, 12 months with view to extend) Clinical Research Officer working on severe asthma projects based at Hunter Medical Research Institute (HMRI) Uni Newcastle Research. Apply by 15th Jan. For PD and selection criteria email [email protected]

Well done Kurtis and team! 🎉💩

I’m looking for a PhD candidate to join my team! Great opportunity to be part of a world leading group in the beautiful city of Newcastle. Open to Australian domestic candidates #phdlife

Absolute pleasure to present, thank you. And shout out to EOSMAN（好酸球くん）, whose illustrations really captured the audience!

Our latest research uncovers different impacts of IL5 pathway biologics on eosinophil subsets in severe #asthma. Eosinophil phenotype tests may enhance monitoring of anti-IL5 response. Open access Allergy EAACI paper here: tinyurl.com/4wmmdmkh.

Looking forwards to presenting our latest research on eosinophil subsets in severe asthma at ERS congress in Vienna, Sunday 8th Sept, 11am-12.15pm Lehar 3, Session 116. Recently published in Allergy EAACI onlinelibrary.wiley.com/doi/10.1111/al…